Correlation Between Nova Leap and NIKE
Can any of the company-specific risk be diversified away by investing in both Nova Leap and NIKE at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nova Leap and NIKE into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nova Leap Health and NIKE Inc CDR, you can compare the effects of market volatilities on Nova Leap and NIKE and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nova Leap with a short position of NIKE. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nova Leap and NIKE.
Diversification Opportunities for Nova Leap and NIKE
Good diversification
The 3 months correlation between Nova and NIKE is -0.05. Overlapping area represents the amount of risk that can be diversified away by holding Nova Leap Health and NIKE Inc CDR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NIKE Inc CDR and Nova Leap is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nova Leap Health are associated (or correlated) with NIKE. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NIKE Inc CDR has no effect on the direction of Nova Leap i.e., Nova Leap and NIKE go up and down completely randomly.
Pair Corralation between Nova Leap and NIKE
Assuming the 90 days horizon Nova Leap Health is expected to generate 2.87 times more return on investment than NIKE. However, Nova Leap is 2.87 times more volatile than NIKE Inc CDR. It trades about 0.03 of its potential returns per unit of risk. NIKE Inc CDR is currently generating about -0.05 per unit of risk. If you would invest 26.00 in Nova Leap Health on October 9, 2024 and sell it today you would earn a total of 1.00 from holding Nova Leap Health or generate 3.85% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 99.8% |
Values | Daily Returns |
Nova Leap Health vs. NIKE Inc CDR
Performance |
Timeline |
Nova Leap Health |
NIKE Inc CDR |
Nova Leap and NIKE Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Nova Leap and NIKE
The main advantage of trading using opposite Nova Leap and NIKE positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nova Leap position performs unexpectedly, NIKE can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NIKE will offset losses from the drop in NIKE's long position.Nova Leap vs. Reliq Health Technologies | Nova Leap vs. NeuPath Health | Nova Leap vs. Bewhere Holdings | Nova Leap vs. AnalytixInsight |
NIKE vs. Titanium Transportation Group | NIKE vs. Quorum Information Technologies | NIKE vs. Aya Gold Silver | NIKE vs. Diamond Estates Wines |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
Commodity Directory Find actively traded commodities issued by global exchanges | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |